2016-03-12T00:00:00.000-05:00
EQIS Capital Management,0.226911
Exchange Commission,0.388695
Celgene Co.,-0.253531
Director Ernest Mario,-0.266538
integrated biopharmaceutical company,0.302063
strong buy rating,0.248773
Roberts Investment Advisors,0.277208
equities research,0.388413
price target,-0.351503
stake,0.212731
stock,0.0299675
recent filing,0.388695
Equities research analysts,0.447612
InvestorPlace Broker Center,0.555736
Renaissance Investment Group,0.252104
firm’s stock,-0.243077
biopharmaceutical company,0.268913
Director Michael D.,-0.219616
personal trading style,0.598412
Nelson Roberts Investment,0.277208
average rating,-0.332466
target price,0.372084
recent SEC filing,0.253026
Celgene,-0.136441
period,0.257862
average price,0.405834
shares,0.0032081
concise daily summary,0.449296
consensus target price,0.435623
stock broker,0.245696
Investment Advisors LLC,0.277208
MUFG Americas,0.294573
equities research analyst,0.329214
quarterly earnings data,-0.274652
quarter,-0.440458
